| http://purl.uniprot.org/citations/37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/37596619 | http://www.w3.org/2000/01/rdf-schema#comment | "There is increasing evidence indicating the significant role of DDX5 (also called p68), acting as a master regulator and a potential biomarker and target, in tumorigenesis, proliferation, metastasis and treatment resistance for cancer therapy. However, DDX5 has also been reported to act as an oncosuppressor. These seemingly contradictory observations can be reconciled by DDX5's role in DNA repair. This is because cancer cell apoptosis and malignant transformation can represent the two possible outcomes of a single process regulated by DDX5, reflecting different intensity of DNA damage. Thus, targeting DDX5 could potentially shift cancer cells from a growth-arrested state (necessary for DNA repair) to apoptosis and cell killing. In addition to the increasingly recognized role of DDX5 in global genome stability surveillance and DNA damage repair, DDX5 has been implicated in multiple oncogenic signaling pathways. DDX5 appears to utilize distinct signaling cascades via interactions with unique proteins in different types of tissues/cells to elicit opposing roles (e.g., smooth muscle cells versus cancer cells). Such unique features make DDX5 an intriguing therapeutic target for the treatment of human cancers, with limited low toxicity to normal tissues. In this review, we discuss the multifaceted functions of DDX5 in DNA repair in cancer, immune suppression, oncogenic metabolic rewiring, virus infection promotion, and negative impact on the human microbiome (microbiota). We also provide new data showing that FL118, a molecular glue DDX5 degrader, selectively works against current treatment-resistant prostate cancer organoids/cells. Altogether, current studies demonstrate that DDX5 may represent a unique oncotarget for effectively conquering cancer with minimal toxicity to normal tissues."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.org/dc/terms/identifier | "doi:10.1186/s13046-023-02787-x"xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Li F."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Liu X."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Wang J."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Chakraborty S."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Tang D.G."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Ling X."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Kalinski P."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Jamroze A."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/author | "Fountzilas C."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/date | "2023"xsd:gYear |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/name | "J Exp Clin Cancer Res"xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/pages | "213"xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/title | "Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence."xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://purl.uniprot.org/core/volume | "42"xsd:string |
| http://purl.uniprot.org/citations/37596619 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/37596619 |
| http://purl.uniprot.org/citations/37596619 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/37596619 |
| http://purl.uniprot.org/uniprot/#_B4DNG2-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |
| http://purl.uniprot.org/uniprot/#_B4DN41-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |
| http://purl.uniprot.org/uniprot/#_B5BUE6-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |
| http://purl.uniprot.org/uniprot/#_J3KTA4-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |
| http://purl.uniprot.org/uniprot/#_P17844-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |
| http://purl.uniprot.org/uniprot/#_Q59E92-mappedCitation-37596619 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/37596619 |